Real-World study tests if lupus drug shields vital organs
NCT ID NCT07056621
Summary
This study aims to see if the drug belimumab can prevent serious organ damage in people with systemic lupus erythematosus (SLE). Researchers will compare 684 patients taking belimumab to similar patients receiving only standard care, using real-world medical records to track who develops new major organ problems. The goal is to understand if this long-used lupus medication can change the disease's course and protect organs like the kidneys, brain, and heart over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital 'Attikon'
RECRUITINGAthens, Attica, 12462, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.